Follow
T A Wilkins
T A Wilkins
Professor of Nanotechnology, Leeds University
Verified email at leeds.ac.uk
Title
Cited by
Cited by
Year
Collaborative diversity in a nanotechnology innovation system: Evidence from the EU Framework Programme
K Pandza, T Wilkins, E Alfoldi
Technovation 31, 476–489, 2011
1082011
Nano (Q) SAR: Challenges, pitfalls and perspectives
R Tantra, C Oksel, T Puzyn, J Wang, KN Robinson, XZ Wang, CY Ma, ...
Nanotoxicology 9 (5), 636-642, 2015
882015
Characterization of Nanoparticle Batch-To-Batch Variability
S Mülhopt, T Diabaté, Silvia, Wilkins, et al
Nanomaterials 8 (5), 1-24, 2018
832018
Characterization of Nanoparticle Batch-To-Batch Variability
S Mulhopt, T Diabate, Silvia, Wilkins
Nanomaterials DOI: 10.3390/nano8050311 8 (311), 24, 2018
832018
(Q)SAR modelling of nanomaterial toxicity: A critical review
C Oksel, CY Ma, JJ Liu, T Wilkins, XZ Wang
Particuology 21, 1-19, 2015
712015
Sensitive test for thyroid hormone autoantibodies in serum
DJ Allan, F Murphy, CA Needham, N Barron, TA Wilkins, JEM Midgley
The Lancet 320 (8302), 824, 1982
681982
Comprehensive study of a thyroxin-analog-based assay for free thyroxin (" Amerlex FT4").
TA Wilkins, JE Midgley, Barron, N
Clinical chemistry 31 (10), 1644-1653, 1985
601985
A comparison of free T4, and the ratio of total T4 to T4-binding globulin in serum through pregnancy
AS Whitworth, JEM Midgley, TA Wilkins
Clinical Endocrinology 17, 307-313, 1982
471982
Electrochemical and morphological investigation of silver and zinc modified calcium phosphate bioceramic coatings on metallic implant materials
M Furko, Y Jiang, TA Wilkins, C Balázsi
Materials Science and Engineering: C 62, 249-259, 2016
442016
Accurate and interpretable nanoSAR models from genetic programming-based decision tree construction approaches
C Oksel, DA Winkler, CY Ma, T Wilkins, XZ Wang
Nanotoxicology 10 (7), 1001-1012, 2016
432016
New methods of free thyroid hormone assay
TA Wilkins, JEM Midgley
Bizollon, Ch.A. (ed.); 370 p; ISBN 0-444-80358-0; Worldcat; 1981; p. 215-234 …, 1981
421981
The direct estimation of free hormones by a simple equilibrium radioimmunoassay
JEM Midgley, TA Wilkins
Amersham: Radiochemical Centre, 1981
401981
EMERGNANO: A review of completed and near completed environment, health and safety research on nanomaterials and nanotechnology
RJ Aitken, SM Hankin, B Ross, CL Tran, V Stone, TF Fernandes, ...
Defra Project CB0409. Edinburgh, UK, Institute of Occupational Medicine, 2009
392009
Understanding the role and impact of poly (ethylene glycol)(PEG) on nanoparticle formulation: Implications for COVID-19 vaccines
E Padín-González, P Lancaster, M Bottini, P Gasco, L Tran, B Fadeel, ...
Frontiers in bioengineering and biotechnology 10, 882363, 2022
382022
Application of isothermal titration calorimetry in evaluation of protein–nanoparticle interactions
E Omanovic-Miklicanin, I Manfield, T Wilkins
Journal of Thermal Analysis and Calorimetry 127, 605-613, 2017
352017
Validity of analog free thyroxin immunoassays. Part II.
JE Midgley, CR Moon, TA Wilkins
Clinical chemistry 33 (12), 2145-2152, 1987
321987
Treatment with heparin and results for free thyroxin: an in vivo or an in vitro effect?
TA Wilkins, JE Midgley, AF Giles
Clinical chemistry 28 (12), 2441-2443, 1982
321982
Risk Management Framework for Nano-Biomaterials Used in Medical Devices and Advanced Therapy Medicinal Products
E Giubilato
Materials 13 (20), 4532, 2020
312020
Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
GM Cree, TA Wilkins, R Monks, DP Nowotnik
US Patent 4,426,453, 1984
311984
Assay for the free portion of substances in biological fluids
JE Midgley, TA Wilkins
US Patent 4,366,143, 1982
281982
The system can't perform the operation now. Try again later.
Articles 1–20